Ancora Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.5K | Sell |
918
-75
| -8% | -$4.12K | ﹤0.01% | 1006 |
|
|
2025
Q1 | $70.2K | Sell |
993
-300
| -23% | -$21.2K | ﹤0.01% | 921 |
|
|
2024
Q4 | $85K | Sell |
1,293
-350
| -21% | -$23K | ﹤0.01% | 869 |
|
|
2024
Q3 | $115K | Sell |
1,643
-150
| -8% | -$10.5K | ﹤0.01% | 779 |
|
|
2024
Q2 | $148K | Hold |
1,793
| – | – | ﹤0.01% | 716 |
|
|
2024
Q1 | $157K | Buy |
1,793
+43
| +2% | +$3.76K | ﹤0.01% | 710 |
|
|
2023
Q4 | $169K | Sell |
1,750
-150
| -8% | -$14.5K | ﹤0.01% | 682 |
|
|
2023
Q3 | $168K | Hold |
1,900
| – | – | ﹤0.01% | 672 |
|
|
2023
Q2 | $165K | Hold |
1,900
| – | – | ﹤0.01% | 670 |
|
|
2023
Q1 | $185K | Hold |
1,900
| – | – | 0.01% | 648 |
|
|
2022
Q4 | $197K | Sell |
1,900
-200
| -10% | -$20.7K | 0.01% | 653 |
|
|
2022
Q3 | $178K | Sell |
2,100
-25
| -1% | -$2.12K | 0.01% | 730 |
|
|
2022
Q2 | $176K | Sell |
2,125
-91
| -4% | -$7.54K | 0.01% | 770 |
|
|
2022
Q1 | $171K | Sell |
2,216
-125
| -5% | -$9.65K | ﹤0.01% | 829 |
|
|
2021
Q4 | $207K | Buy |
2,341
+1,916
| +451% | +$169K | ﹤0.01% | 783 |
|
|
2021
Q3 | $33K | Buy |
425
+350
| +467% | +$27.2K | ﹤0.01% | 1294 |
|
|
2021
Q2 | $6K | Hold |
75
| – | – | ﹤0.01% | 1620 |
|
|
2021
Q1 | $6K | Hold |
75
| – | – | ﹤0.01% | 1488 |
|
|
2020
Q4 | $7K | Sell |
75
-200
| -73% | -$18.7K | ﹤0.01% | 1223 |
|
|
2020
Q3 | $21K | Hold |
275
| – | – | ﹤0.01% | 979 |
|
|
2020
Q2 | $34K | Hold |
275
| – | – | ﹤0.01% | 868 |
|
|
2020
Q1 | $23K | Buy |
+275
| New | +$23K | ﹤0.01% | 985 |
|